Takeda Makes Fresh AI Drug Discovery Bet With Insilico Medicine
Insilico Medicine said Thursday it entered into a strategic collaboration with Takeda Pharmaceutical Co. Ltd. (NYSE: TAK ) to use its proprietary Pharma.AI platform to discover and advance new drug candidates across multiple therapeutic areas. Deal Includes Upfront Payments And Future Milestones As part of the collabor